Geneva: The World Health Organisation (WHO) on Friday said it has suspended Gilead's Remdesivir from its so-called prequalification list (an official list of medicines used as a benchmark for procurement ...
New Delhi: Gilead Sciences Inc's remdesivir had little or no effect on the length of hospital stay of COVID patients or their chances of survival, a clinical trial by the ...
New Delhi: Union Health Minister Dr Harsh Vardhan has said that the Centre is inspecting the coronavirus reinfection cases, along with every novel aspect of the virus. The minister assured ...
Adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their recovery time by an additional day, said the drug company Eli Lilly on Monday. ...
Remdesivir has been launched under the brand name Remdac in the Indian market. Meant to treat patients suffering from severe symptoms of COVID-19, it will be priced at Rs 2,800 ...
Ahmedabad: If everything goes according to plan, Zydus Cadila will complete trials for its COVID-19 vaccine by February or March next year, company chairman Pankaj Patel said on Friday and ...
New York: Remdesivir, the anti-viral drug that has shown promise in the fight against COVID-19, has been backed by more researchers. A recent study, published in the journal Cell Reports, ...
New Delhi: Remdesivir will be available to patients in India this month. Mylan NV announced on Monday that the Drug Controller General of India (DCGI) has approved it for restricted ...
New Delhi: Amid rising cases of coronavirus, there are reports about supply shortage and selling of two life-saving drugs — remdesivir and tocilizumab — for exorbitant rates on old Delhi's ...
Bhubaneswar: About 1,200 strips of Fabi Flu (Favipiravir) tablets to cure patients with mild to moderate coronavirus are scheduled to arrive in Odisha on Monday. Drugs Controller Mamina Patnaik informed ...
Copyright © 2024 Frontier Media
